Ligand-targeted liposomes directed against pathological vasculature

G Molema; TLM ten Hagen; Adrienne P.C.A. Janssen; AJ Schraa; RJ Kok; GA Koning; G Storm

doi:10.1081/LPR-120004785

Ligand-targeted liposomes directed against pathological vasculature

G Molema, TLM ten Hagen, Adrienne P.C.A. Janssen, AJ Schraa, RJ Kok, GA Koning, G Storm

Onderzoeksoutput: Article › Academic › peer review

18 Citaten (Scopus)

56 Downloads (Pure)

Samenvatting

The development of liposomes targeted to angiogenic endothelial cells offers exciting prospects for intervention in cancer and inflammation. Several proteins are (strongly) over-expressed on angiogenic endothelial cells as compared to the quiescent endothelium, and could potentially serve as targets for site-specific drug delivery. In this contribution particular attention is given to the design of targeted long-circulating liposomes directed against the alpha v beta 3-integrin protein.

Originele taal-2	English
Pagina's (van-tot)	129-135
Aantal pagina's	7
Tijdschrift	Journal of Liposome Research
Volume	12
Nummer van het tijdschrift	1-2
DOI's	https://doi.org/10.1081/LPR-120004785
Status	Published - 2002
Evenement	5th International Conference on Liposome Advances - Duur: 17-dec.-2001 → 21-dec.-2001

Toegang tot document

10.1081/LPR-120004785

Ligand-targeted liposomes directed against pathological vasculatureFinal publisher's version, 195 KBLicentie: Taverne

Handle.net

Permanente koppeling

Citeer dit

@article{cf45f4a84d65460686ca04aefc9b369a,

title = "Ligand-targeted liposomes directed against pathological vasculature",

abstract = "The development of liposomes targeted to angiogenic endothelial cells offers exciting prospects for intervention in cancer and inflammation. Several proteins are (strongly) over-expressed on angiogenic endothelial cells as compared to the quiescent endothelium, and could potentially serve as targets for site-specific drug delivery. In this contribution particular attention is given to the design of targeted long-circulating liposomes directed against the alpha v beta 3-integrin protein.",

keywords = "angiogenesis, integrins, RGD-peptide, drug targeting, liposomes, ANGIOGENESIS, CANCER, INFLAMMATION, MECHANISMS, THERAPIES, DISEASES, AGENTS",

author = "G Molema and {ten Hagen}, TLM and Janssen, {Adrienne P.C.A.} and AJ Schraa and RJ Kok and GA Koning and G Storm",

year = "2002",

doi = "10.1081/LPR-120004785",

language = "English",

volume = "12",

pages = "129--135",

journal = "Journal of Liposome Research",

issn = "0898-2104",

publisher = "Taylor & Francis Group",

number = "1-2",

note = "5th International Conference on Liposome Advances ; Conference date: 17-12-2001 Through 21-12-2001",

}

TY - JOUR

T1 - Ligand-targeted liposomes directed against pathological vasculature

AU - Molema, G

AU - ten Hagen, TLM

AU - Janssen, Adrienne P.C.A.

AU - Schraa, AJ

AU - Kok, RJ

AU - Koning, GA

AU - Storm, G

PY - 2002

Y1 - 2002

N2 - The development of liposomes targeted to angiogenic endothelial cells offers exciting prospects for intervention in cancer and inflammation. Several proteins are (strongly) over-expressed on angiogenic endothelial cells as compared to the quiescent endothelium, and could potentially serve as targets for site-specific drug delivery. In this contribution particular attention is given to the design of targeted long-circulating liposomes directed against the alpha v beta 3-integrin protein.

AB - The development of liposomes targeted to angiogenic endothelial cells offers exciting prospects for intervention in cancer and inflammation. Several proteins are (strongly) over-expressed on angiogenic endothelial cells as compared to the quiescent endothelium, and could potentially serve as targets for site-specific drug delivery. In this contribution particular attention is given to the design of targeted long-circulating liposomes directed against the alpha v beta 3-integrin protein.

KW - angiogenesis

KW - integrins

KW - RGD-peptide

KW - drug targeting

KW - liposomes

KW - ANGIOGENESIS

KW - CANCER

KW - INFLAMMATION

KW - MECHANISMS

KW - THERAPIES

KW - DISEASES

KW - AGENTS

U2 - 10.1081/LPR-120004785

DO - 10.1081/LPR-120004785

M3 - Article

SN - 0898-2104

VL - 12

SP - 129

EP - 135

JO - Journal of Liposome Research

JF - Journal of Liposome Research

IS - 1-2

T2 - 5th International Conference on Liposome Advances

Y2 - 17 December 2001 through 21 December 2001

ER -

Ligand-targeted liposomes directed against pathological vasculature

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit